文献速递腹部技术与安全CT

对比剂对CT辐射剂量的影响:第二部分——跨58个患者模型的系统评估

The Effect of Contrast Material on Radiation Dose at CT: Part II. A Systematic Evaluation across 58 Patient Models.
PubMed 文献 · Radiology · 2017-03-13

该研究将对比剂增强的计算患者模型用于典型腹部CT检查,通过蒙特卡洛模拟评估各器官随时间变化的辐射剂量。结果显示注射对比剂后心脏、脾、肝、肾等器官总辐射剂量最高增加53%至17%不等,而具有生物学相关性的剂量增加在肝脏为0%-18%、肾脏为27%。作者认为设计CT协议时需考虑碘对比剂对器官剂量的影响。

要点

  • 注射对比剂后器官总辐射剂量增加,心脏最高达53%,肾脏达54%。
  • 具有生物学相关性的剂量增加在肝脏为0%-18%、肾脏为27%。
  • 作者建议设计CT协议时考虑碘对比剂对器官剂量的影响。

核心结论

  • 给予对比剂会增加总辐射剂量,但辐射剂量可能仍不能完全反映总的生物学效应。
  • 鉴于许多CT诊断决策离不开碘对比剂,本研究提示设计CT协议时需考虑碘对比剂对患者器官剂量的影响。

研究设计与样本

  • 本研究为假设生成性研究,将第一部分所述技术应用于扩展心脏-躯干模型,使其具有反映对比剂注射的患者特异性碘-时间曲线。
  • 采用蒙特卡洛模拟在典型腹部CT检查中评估患者特异性器官剂量随时间的变化,共涉及58个患者模型。
  • 器官剂量指包括碘在内的单位质量组织沉积的总能量;另开展研究以预估肝、肾等高灌注器官的生物学相关剂量(组织吸收剂量)。

诊断标准与关键数值

  • 相对于平扫CT,心脏、脾、肝、肾、胃、结肠、小肠、胰腺的辐射剂量分别最高增加53%、30%、35%、54%、27%、18%、17%、24%。
  • 具有生物学相关性的剂量较平扫CT的增加幅度:肝脏为0%-18%,肾脏为27%,基于58个患者模型。

临床应用与阅片要点

  • 作者建议设计CT协议时考虑碘对比剂对器官剂量的影响。
  • 作者指出辐射剂量虽应纳入对比增强CT相关风险的评估,但可能仍不能完全反映总的生物学效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To estimate the radiation dose as a result of contrast medium administration in a typical abdominal computed tomographic (CT) examination across a library of contrast material-enhanced computational patient models. Materials and Methods In part II of this study, first, the technique described in part I of this study was applied to enhance the extended cardiac-torso models with patient-specific iodine-time profiles reflecting the administration of contrast material. Second, the patient models were deployed to assess the patient-specific organ dose as a function of time in a typical abdominal CT examination using Monte Carlo simulation. In this hypothesis-generating study, organ dose refers to the total energy deposited in the unit mass of the tissue inclusive of iodine. Third, a study was performed as a strategy to anticipate the biologically relevant dose (absorbed dose to tissue) in highly perfused organs such as the liver and kidney. The time-varying organ-dose increment values relative to those for unenhanced CT examinations were reported. Results The results from the patient models subjected to the injection protocol indicated up to a total 53%, 30%, 35%, 54%, 27%, 18%, 17%, and 24% increase in radiation dose delivered to the heart, spleen, liver, kidneys, stomach, colon, small intestine, and pancreas, respectively. The biologically relevant dose increase with respect to the dose at an unenhanced CT examination was in the range of 0%-18% increase for the liver and 27% for the kidney across 58 patient models. Conclusion The administration of contrast medium increases the total radiation dose. However, radiation dose, while relevant to be included in estimating the risk associated with contrast-enhanced CT, may still not fully characterize the total biologic effects. Therefore, given the fact that many CT diagnostic decisions would be impossible without the use of iodine, this study suggests the need to consider the effect of iodinated contrast material on the organ doses to patients undergoing CT studies when designing CT protocols. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Sahbaee P, Abadi E, Segars WP, et al. The Effect of Contrast Material on Radiation Dose at CT: Part II. A Systematic Evaluation across 58 Patient Models. Radiology. 2017. PMID: 28287916. doi:10.1148/radiol.2017152852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。